Correspondence 0000950170-24-138951 from REVELATION BIOSCIENCES, INC. (REVB)
REVELATION BIOSCIENCES, INC.
Date: Dec. 20, 2024 · CIK: 0001810560 · Accession: 0000950170-24-138951
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283764
Letter
Revelation Biosciences, Inc.
4660 La Jolla Village Drive, Suite 100
San Diego, California 92122
December 20, 2024
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Chris Edwards
Re:
Revelation Biosciences, Inc.
Registration Statement on Form S-3
Commission File No. 333-283764
Mr. Edwards:
On behalf of Revelation Biosciences, Inc. (the “Company”), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on December 20, 2024, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Revelation Biosciences, Inc.
4660 La Jolla Village Drive, Suite 100
San Diego, California 92122
December 20, 2024
Via EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Attention:
Chris Edwards
Re:
Revelation Biosciences, Inc.
Registration Statement on Form S-3
Commission File No. 333-283764
Mr. Edwards:
On behalf of Revelation Biosciences, Inc. (the “Company”), I hereby request that the Commission declare effective the above-captioned registration statement at 5:00pm on December 20, 2024, or as soon thereafter as practicable. Please call or email our counsel, J.P. Galda, with any further questions or comments.
Very truly yours,
Revelation Biosciences, Inc.
/s/ Chester S. Zygmont, III
Chief Financial Officer